A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2011
11/30/2011	CN101336244B 用作蛋白激酶抑制剂的9元杂二环化合物 Used as a protein kinase inhibitor compound 9 yuan heterobicycle
11/30/2011	CN101138569B 提高吲哚-3-甲醇及其衍生物疗效的药物组合物 Improve indol-3-methanol and its derivatives pharmaceutical composition efficacy
11/29/2011	US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067569 Splice-region antisense composition and method
11/29/2011	US8067540 Human ALEX1 proteins
11/29/2011	US8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067394 Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
11/29/2011	US8067375 Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor
11/29/2011	US8067372 Modulation of angiogenesis by A-beta peptide fragments
11/29/2011	US8067240 Methods for the diagnosis and treatment of lung cancer
11/29/2011	US8067219 Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
11/29/2011	US8067186 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067012 Treatment of melanoma using HSV mutant
11/29/2011	US8067007 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	US8067000 Cancer treatment with endothelin receptor antagonists
11/29/2011	US8066985 Reovirus for the treatment of cellular proliferative disorders
11/29/2011	DE202011001708U1 Kosmetisches Polymer-Gel mit heilender Wirkung Cosmetic polymer gel with healing properties
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2658359C Heterocyclic compounds and methods of use
11/29/2011	CA2650248C Compounds and compositions as hedgehog pathway modulators
11/29/2011	CA2584142C Improved viral purification methods
11/29/2011	CA2579032C Use of an .delta.-amino acid as thymocyte growth agent
11/29/2011	CA2569739C Antitumor effect potentiator, antitumor preparation, and method for treating cancer
11/29/2011	CA2526022C Sulfotransferase inhibitor
11/29/2011	CA2522535C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2011	CA2494345C Combination of an aromatase inhibitor with a bisphosphonate
11/29/2011	CA2484166C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/29/2011	CA2465757C Triazole derivatives as cyclooxygenase (cox) inhibitors
11/29/2011	CA2456327C Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/29/2011	CA2453843C Substituted 4-aminocyclohexanol derivatives
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/29/2011	CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011	CA2406080C Antitumoral ecteinascidin derivatives
11/29/2011	CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
11/29/2011	CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/29/2011	CA2371226C 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
11/29/2011	CA2346931C Gene delivery system and methods of use
11/29/2011	CA2233447C Mimicking peptides in cancer therapy
11/24/2011	WO2011146938A1 Reagents and methods for treating cancer
11/24/2011	WO2011146803A1 Method of treating lung adenocarcinoma with hsp90 inhibitory compounds
11/24/2011	WO2011146801A1 Formulation and dosing of hsp90 inhibitory compounds
11/24/2011	WO2011146635A1 Malignant neoplasm treatment protocol
11/24/2011	WO2011146408A1 Hpma polymer platinum chelates
11/24/2011	WO2011146382A1 Improved immunotherapeutic dosing regimens and combinations thereof
11/24/2011	WO2011146287A1 Pyrazolo[4,3-b]pyridine-7-amine inhibitors of alk5
11/24/2011	WO2011145770A1 Method for removing allergen of lacquer tree
11/24/2011	WO2011145744A1 Anti-human trop-2 antibody having antitumor activity in vivo
11/24/2011	WO2011145629A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION
11/24/2011	WO2011145548A1 Crystals of di(arylamino)aryl compound
11/24/2011	WO2011145518A1 Aldehyde removing composition
11/24/2011	WO2011145125A1 Chimeric biomarker for the early diagnosis and immunotherapy of cancer
11/24/2011	WO2011145068A1 Novel self-reactive arms and prodrugs comprising same
11/24/2011	WO2011145035A1 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
11/24/2011	WO2011144749A1 Biological materials related to her3
11/24/2011	WO2011144742A1 Novel pyrimidine derivatives
11/24/2011	WO2011144721A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
11/24/2011	WO2011144584A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/24/2011	WO2011144059A1 Fused quinazoline derivatives and uses thereof
11/24/2011	WO2011144020A1 Indenoquinolone compound, preparation method and use thereof
11/24/2011	WO2011143864A1 Anticancer compounds and preparation methods thereof
11/24/2011	WO2011143762A1 Method for reducing expression of downregulated iν renal cell carcinoma iν malignant gliomas
11/24/2011	WO2011120135A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011120134A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011097581A9 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES
11/24/2011	WO2011092295A3 Radioimmunoconjugates and uses thereof
11/24/2011	WO2011090738A3 Type ii raf kinase inhibitors
11/24/2011	WO2011090266A3 Novel tumor antigen protein agr2 and tumor antigenic peptide thereof
11/24/2011	WO2011084458A3 Polymer-based compositions and methods for treatment of peritoneal disorders
11/24/2011	WO2011082267A3 Substituted triazolo-pyrazine compounds
11/24/2011	WO2011079193A3 Preparation of bendamustine and its salts
11/24/2011	WO2011079142A3 Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
11/24/2011	WO2011062909A3 Creating bioengineered lymph nodes
11/24/2011	WO2011062786A3 Compounds and methods for inhibiting the metastasis of cancer cells
11/24/2011	WO2011054001A3 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use
11/24/2011	WO2011050000A3 Single molecule nucleic acid nanoparticles
11/24/2011	WO2011040973A3 Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof
11/24/2011	WO2011036558A3 Crystalline methylthionium chloride (methylene blue) hydrates
11/24/2011	WO2010134047A3 Liquid dosage forms of isotretinoin
11/24/2011	US20110289608 Antisense modulation of interleukins 17 and 23 signaling
11/24/2011	US20110288472 Bladder cancer treatment and methods
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288177 Methods for Preventing or Reducing Colon Carcinogenesis
11/24/2011	US20110288176 Ethacrynic acid-containing composition for prevention or treatment of transglutaminase-related diseases and method for prevention or treatment of transglutaminase-related diseases using the same
11/24/2011	US20110288166 Triptolide c-ring derivatives as anticancer agents and immune modulators
11/24/2011	US20110288162 Transition metal complexes of a bis[thio-hydrazide amide] compounds
11/24/2011	US20110288159 Methods of expressing a polypeptide in the brain and nucleic acid constructs capable of same
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288152 Psma binding ligand-linker conjugates and methods for using
11/24/2011	US20110288151 Methods of characterizing breast cancer and identifying treatments for same
11/24/2011	US20110288150 Oligonucleotides for Suppressing Cancer Cell Invasion and Migration
11/24/2011	US20110288147 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop
11/24/2011	US20110288144 Use of hdac inhibitors for the treatment of melanoma
11/24/2011	US20110288143 Bladder cancer treatment and methods
11/24/2011	US20110288142 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
11/24/2011	US20110288133 Histone deacetylase inhibitors

1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 2211